Cargando…
A New Isolated Mediastinal Lymph Node or Small Pulmonary Nodule Arising during Breast Cancer Surveillance Following Curative Surgery: Clinical Factors That Differentiate Malignant from Benign Lesions
PURPOSE: A newly isolated mediastinal lymph node (LN) or a small pulmonary nodule, which appears during breast cancer surveillance, may pose a diagnostic dilemma with regard to malignancy. We conducted this study to determine which clinical factors were useful for the differentiation of malignant le...
Autores principales: | , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Cancer Association
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4132446/ https://www.ncbi.nlm.nih.gov/pubmed/25038763 http://dx.doi.org/10.4143/crt.2014.46.3.280 |
_version_ | 1782330628185784320 |
---|---|
author | Kim, Tae-Yong Lee, Kyung-Hun Han, Sae-Won Oh, Do-Youn Im, Seock-Ah Kim, Tae-You Han, Wonshik Kim, Kyubo Chie, Eui Kyu Park, In-Ae Kim, Young Tae Noh, Dong-Young Ha, Sung Whan Bang, Yung-Jue |
author_facet | Kim, Tae-Yong Lee, Kyung-Hun Han, Sae-Won Oh, Do-Youn Im, Seock-Ah Kim, Tae-You Han, Wonshik Kim, Kyubo Chie, Eui Kyu Park, In-Ae Kim, Young Tae Noh, Dong-Young Ha, Sung Whan Bang, Yung-Jue |
author_sort | Kim, Tae-Yong |
collection | PubMed |
description | PURPOSE: A newly isolated mediastinal lymph node (LN) or a small pulmonary nodule, which appears during breast cancer surveillance, may pose a diagnostic dilemma with regard to malignancy. We conducted this study to determine which clinical factors were useful for the differentiation of malignant lesions from benign lesions under these circumstances. MATERIALS AND METHODS: We enrolled breast cancer patients who were presented with a new isolated mediastinal LN or small pulmonary nodule that arose during surveillance, and whose lesions were pathologically confirmed. Tissue diagnosis was made by mediastinoscopy, video-assisted thoracic surgery or thoracotomy. RESULTS: A total of 43 patients were enrolled (mediastinal LN, 13 patients; pulmonary nodule, 30 patients). Eighteen patients (41.9%) were pathologically confirmed to have a benign lesion (benign group), and 25 patients (58.1%) were confirmed to have malignant lesion (malignant group). Between the two groups, the initial tumor size (p=0.096) and N stage (p=0.749) were similar. Hormone receptor negativity was more prevalent in the malignant group (59.1% vs. 40.9%, p=0.048). The mean lesion size was larger in the malignant group than in the benign group (20.8 mm vs. 14.4 mm, p=0.024). Metastatic lesions had a significantly higher value of maximal standardized uptake (mSUV) than that of benign lesions (6.4 vs. 3.4, p=0.021). CONCLUSION: Hormone receptor status, lesion size, and mSUV on positron emission tomography are helpful in the differentiation of malignant lesions from benign lesions in breast cancer patients who were presented with a new isolated mediastinal LN or small pulmonary nodule during surveillance. |
format | Online Article Text |
id | pubmed-4132446 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | Korean Cancer Association |
record_format | MEDLINE/PubMed |
spelling | pubmed-41324462014-08-20 A New Isolated Mediastinal Lymph Node or Small Pulmonary Nodule Arising during Breast Cancer Surveillance Following Curative Surgery: Clinical Factors That Differentiate Malignant from Benign Lesions Kim, Tae-Yong Lee, Kyung-Hun Han, Sae-Won Oh, Do-Youn Im, Seock-Ah Kim, Tae-You Han, Wonshik Kim, Kyubo Chie, Eui Kyu Park, In-Ae Kim, Young Tae Noh, Dong-Young Ha, Sung Whan Bang, Yung-Jue Cancer Res Treat Original Article PURPOSE: A newly isolated mediastinal lymph node (LN) or a small pulmonary nodule, which appears during breast cancer surveillance, may pose a diagnostic dilemma with regard to malignancy. We conducted this study to determine which clinical factors were useful for the differentiation of malignant lesions from benign lesions under these circumstances. MATERIALS AND METHODS: We enrolled breast cancer patients who were presented with a new isolated mediastinal LN or small pulmonary nodule that arose during surveillance, and whose lesions were pathologically confirmed. Tissue diagnosis was made by mediastinoscopy, video-assisted thoracic surgery or thoracotomy. RESULTS: A total of 43 patients were enrolled (mediastinal LN, 13 patients; pulmonary nodule, 30 patients). Eighteen patients (41.9%) were pathologically confirmed to have a benign lesion (benign group), and 25 patients (58.1%) were confirmed to have malignant lesion (malignant group). Between the two groups, the initial tumor size (p=0.096) and N stage (p=0.749) were similar. Hormone receptor negativity was more prevalent in the malignant group (59.1% vs. 40.9%, p=0.048). The mean lesion size was larger in the malignant group than in the benign group (20.8 mm vs. 14.4 mm, p=0.024). Metastatic lesions had a significantly higher value of maximal standardized uptake (mSUV) than that of benign lesions (6.4 vs. 3.4, p=0.021). CONCLUSION: Hormone receptor status, lesion size, and mSUV on positron emission tomography are helpful in the differentiation of malignant lesions from benign lesions in breast cancer patients who were presented with a new isolated mediastinal LN or small pulmonary nodule during surveillance. Korean Cancer Association 2014-07 2014-07-15 /pmc/articles/PMC4132446/ /pubmed/25038763 http://dx.doi.org/10.4143/crt.2014.46.3.280 Text en Copyright © 2014 by the Korean Cancer Association This is an Open-Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Original Article Kim, Tae-Yong Lee, Kyung-Hun Han, Sae-Won Oh, Do-Youn Im, Seock-Ah Kim, Tae-You Han, Wonshik Kim, Kyubo Chie, Eui Kyu Park, In-Ae Kim, Young Tae Noh, Dong-Young Ha, Sung Whan Bang, Yung-Jue A New Isolated Mediastinal Lymph Node or Small Pulmonary Nodule Arising during Breast Cancer Surveillance Following Curative Surgery: Clinical Factors That Differentiate Malignant from Benign Lesions |
title | A New Isolated Mediastinal Lymph Node or Small Pulmonary Nodule Arising during Breast Cancer Surveillance Following Curative Surgery: Clinical Factors That Differentiate Malignant from Benign Lesions |
title_full | A New Isolated Mediastinal Lymph Node or Small Pulmonary Nodule Arising during Breast Cancer Surveillance Following Curative Surgery: Clinical Factors That Differentiate Malignant from Benign Lesions |
title_fullStr | A New Isolated Mediastinal Lymph Node or Small Pulmonary Nodule Arising during Breast Cancer Surveillance Following Curative Surgery: Clinical Factors That Differentiate Malignant from Benign Lesions |
title_full_unstemmed | A New Isolated Mediastinal Lymph Node or Small Pulmonary Nodule Arising during Breast Cancer Surveillance Following Curative Surgery: Clinical Factors That Differentiate Malignant from Benign Lesions |
title_short | A New Isolated Mediastinal Lymph Node or Small Pulmonary Nodule Arising during Breast Cancer Surveillance Following Curative Surgery: Clinical Factors That Differentiate Malignant from Benign Lesions |
title_sort | new isolated mediastinal lymph node or small pulmonary nodule arising during breast cancer surveillance following curative surgery: clinical factors that differentiate malignant from benign lesions |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4132446/ https://www.ncbi.nlm.nih.gov/pubmed/25038763 http://dx.doi.org/10.4143/crt.2014.46.3.280 |
work_keys_str_mv | AT kimtaeyong anewisolatedmediastinallymphnodeorsmallpulmonarynodulearisingduringbreastcancersurveillancefollowingcurativesurgeryclinicalfactorsthatdifferentiatemalignantfrombenignlesions AT leekyunghun anewisolatedmediastinallymphnodeorsmallpulmonarynodulearisingduringbreastcancersurveillancefollowingcurativesurgeryclinicalfactorsthatdifferentiatemalignantfrombenignlesions AT hansaewon anewisolatedmediastinallymphnodeorsmallpulmonarynodulearisingduringbreastcancersurveillancefollowingcurativesurgeryclinicalfactorsthatdifferentiatemalignantfrombenignlesions AT ohdoyoun anewisolatedmediastinallymphnodeorsmallpulmonarynodulearisingduringbreastcancersurveillancefollowingcurativesurgeryclinicalfactorsthatdifferentiatemalignantfrombenignlesions AT imseockah anewisolatedmediastinallymphnodeorsmallpulmonarynodulearisingduringbreastcancersurveillancefollowingcurativesurgeryclinicalfactorsthatdifferentiatemalignantfrombenignlesions AT kimtaeyou anewisolatedmediastinallymphnodeorsmallpulmonarynodulearisingduringbreastcancersurveillancefollowingcurativesurgeryclinicalfactorsthatdifferentiatemalignantfrombenignlesions AT hanwonshik anewisolatedmediastinallymphnodeorsmallpulmonarynodulearisingduringbreastcancersurveillancefollowingcurativesurgeryclinicalfactorsthatdifferentiatemalignantfrombenignlesions AT kimkyubo anewisolatedmediastinallymphnodeorsmallpulmonarynodulearisingduringbreastcancersurveillancefollowingcurativesurgeryclinicalfactorsthatdifferentiatemalignantfrombenignlesions AT chieeuikyu anewisolatedmediastinallymphnodeorsmallpulmonarynodulearisingduringbreastcancersurveillancefollowingcurativesurgeryclinicalfactorsthatdifferentiatemalignantfrombenignlesions AT parkinae anewisolatedmediastinallymphnodeorsmallpulmonarynodulearisingduringbreastcancersurveillancefollowingcurativesurgeryclinicalfactorsthatdifferentiatemalignantfrombenignlesions AT kimyoungtae anewisolatedmediastinallymphnodeorsmallpulmonarynodulearisingduringbreastcancersurveillancefollowingcurativesurgeryclinicalfactorsthatdifferentiatemalignantfrombenignlesions AT nohdongyoung anewisolatedmediastinallymphnodeorsmallpulmonarynodulearisingduringbreastcancersurveillancefollowingcurativesurgeryclinicalfactorsthatdifferentiatemalignantfrombenignlesions AT hasungwhan anewisolatedmediastinallymphnodeorsmallpulmonarynodulearisingduringbreastcancersurveillancefollowingcurativesurgeryclinicalfactorsthatdifferentiatemalignantfrombenignlesions AT bangyungjue anewisolatedmediastinallymphnodeorsmallpulmonarynodulearisingduringbreastcancersurveillancefollowingcurativesurgeryclinicalfactorsthatdifferentiatemalignantfrombenignlesions AT kimtaeyong newisolatedmediastinallymphnodeorsmallpulmonarynodulearisingduringbreastcancersurveillancefollowingcurativesurgeryclinicalfactorsthatdifferentiatemalignantfrombenignlesions AT leekyunghun newisolatedmediastinallymphnodeorsmallpulmonarynodulearisingduringbreastcancersurveillancefollowingcurativesurgeryclinicalfactorsthatdifferentiatemalignantfrombenignlesions AT hansaewon newisolatedmediastinallymphnodeorsmallpulmonarynodulearisingduringbreastcancersurveillancefollowingcurativesurgeryclinicalfactorsthatdifferentiatemalignantfrombenignlesions AT ohdoyoun newisolatedmediastinallymphnodeorsmallpulmonarynodulearisingduringbreastcancersurveillancefollowingcurativesurgeryclinicalfactorsthatdifferentiatemalignantfrombenignlesions AT imseockah newisolatedmediastinallymphnodeorsmallpulmonarynodulearisingduringbreastcancersurveillancefollowingcurativesurgeryclinicalfactorsthatdifferentiatemalignantfrombenignlesions AT kimtaeyou newisolatedmediastinallymphnodeorsmallpulmonarynodulearisingduringbreastcancersurveillancefollowingcurativesurgeryclinicalfactorsthatdifferentiatemalignantfrombenignlesions AT hanwonshik newisolatedmediastinallymphnodeorsmallpulmonarynodulearisingduringbreastcancersurveillancefollowingcurativesurgeryclinicalfactorsthatdifferentiatemalignantfrombenignlesions AT kimkyubo newisolatedmediastinallymphnodeorsmallpulmonarynodulearisingduringbreastcancersurveillancefollowingcurativesurgeryclinicalfactorsthatdifferentiatemalignantfrombenignlesions AT chieeuikyu newisolatedmediastinallymphnodeorsmallpulmonarynodulearisingduringbreastcancersurveillancefollowingcurativesurgeryclinicalfactorsthatdifferentiatemalignantfrombenignlesions AT parkinae newisolatedmediastinallymphnodeorsmallpulmonarynodulearisingduringbreastcancersurveillancefollowingcurativesurgeryclinicalfactorsthatdifferentiatemalignantfrombenignlesions AT kimyoungtae newisolatedmediastinallymphnodeorsmallpulmonarynodulearisingduringbreastcancersurveillancefollowingcurativesurgeryclinicalfactorsthatdifferentiatemalignantfrombenignlesions AT nohdongyoung newisolatedmediastinallymphnodeorsmallpulmonarynodulearisingduringbreastcancersurveillancefollowingcurativesurgeryclinicalfactorsthatdifferentiatemalignantfrombenignlesions AT hasungwhan newisolatedmediastinallymphnodeorsmallpulmonarynodulearisingduringbreastcancersurveillancefollowingcurativesurgeryclinicalfactorsthatdifferentiatemalignantfrombenignlesions AT bangyungjue newisolatedmediastinallymphnodeorsmallpulmonarynodulearisingduringbreastcancersurveillancefollowingcurativesurgeryclinicalfactorsthatdifferentiatemalignantfrombenignlesions |